You are here

  • Home
  • Archive
  • Volume 11, Issue 7
  • Correction: Short-term dynamics of circulating tumor DNA predicting efficacy of sintilimab plus docetaxel in second-line treatment of advanced NSCLC: biomarker analysis from a single-arm, phase 2 trial

Article metrics

Article menu

See original article:

Download PDFPDF

Correction
Correction: Short-term dynamics of circulating tumor DNA predicting efficacy of sintilimab plus docetaxel in second-line treatment of advanced NSCLC: biomarker analysis from a single-arm, phase 2 trial

 

Online download statistics by month:

Online download statistics by month: July 2023 to August 2025

AbstractFullPdf
Jul 2023014225
Aug 2023010118
Sep 20230414
Oct 20230327
Nov 20230444
Dec 20230318
Jan 20240268
Feb 20240245
Mar 202401321
Apr 202401617
May 20240153
Jun 20240164
Jul 20240235
Aug 20240158
Sep 20240255
Oct 20240177
Nov 20240134
Dec 20240405
Jan 20250179
Feb 20250145
Mar 20250229
Apr 20250252
May 20250107
Jun 20250185
Jul 2025010
Aug 2025010
Total0742195